-
admin
Posts
MTE HCMC 2025 – Connecting Vietnamese Developers and Industry Experts at Vietnam’s Premier Real Estate & Hospitality Conference
HO CHI MINH CITY, Vietnam, Feb. 27, 2025 /PRNewswire/ — Riding on the back of a very positive year for the hospitality market in Vietnam,...
Olaplex Holdings, Inc. Announces Participation in the Raymond James 46th Annual Institutional Investors Conference on March 5th
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (“OLAPLEX”), today announced its participation in the Raymond James 46th Annual Institutional Investors Conference...
The Cosmetic Dyes Market: 2025-2030 Strategic Business Report
Gain insights into the U.S. market, valued at $105.5 Million in 2024, and China, forecasted to grow at an impressive 9.8% CAGR to reach $140.1...
Laser Hair Removal Market to Reach $7.7 billion, Globally, by 2035 at 18.3% CAGR: Allied Market Research
Wilmington, Delaware, Feb. 26, 2025 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Laser Hair Removal Market by Type (Alexandrite laser hair removal,...
Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma
FDA decision expected by July 30, 2025 TARRYTOWN, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S....
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
KIMMTRAK (tebentafusp) Q4 net sales of $84.1 million and $310.0 million for full year 2024; continued growth expected in 2025 Executing on KIMMTRAK lifecycle management...
Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025
Company to Host Conference Call at 8:00am ET REHOVOT, Israel, and HOBOKEN, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA),...
Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2024
BANNOCKBURN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) — Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider...
Passage Bio to Participate in Upcoming Investor Conferences
PHILADELPHIA, Feb. 26, 2025 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients...
Arhaus Reports Fourth Quarter and Full Year 2024 Financial Results
BOSTON HEIGHTS, Ohio, Feb. 26, 2025 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of...
